Search

Your search keyword '"Labetalol adverse effects"' showing total 341 results

Search Constraints

Start Over You searched for: Descriptor "Labetalol adverse effects" Remove constraint Descriptor: "Labetalol adverse effects"
341 results on '"Labetalol adverse effects"'

Search Results

1. Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension.

2. Pharmacogenomics of Preeclampsia therapies: Current evidence and future challenges for clinical implementation.

3. Labetalol Ameliorates Experimental Colitis in Rat Possibly Through its Effect on Proinflammatory Mediators and Oxidative Stress.

4. Comparing the efficacy of oral labetalol with oral amlodipine in achieving blood pressure control in women with postpartum hypertension: randomized controlled trial (HIPPO study-Hypertension In Pregnancy & Postpartum Oral-antihypertensive therapy).

5. Safety and efficacy of continuous intravenous labetalol for blood pressure control in neurosurgical patients.

6. A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA).

7. Hypertension in Pregnancy: A Diagnostic and Therapeutic Overview.

8. Reduction of Intravenous Antihypertensives through Clinical Decision Support in a Large Safety Net System.

9. Labetalol, Low-dose Aspirin, and Vitamin E and Calcium for Gestational Hypertension and Influence on MicroRNA-126 and PLGF Levels.

10. Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.

11. Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension.

12. Nicardipine versus Labetalol for Hypertension during Acute Stroke: A Systematic Review and Meta-Analysis.

14. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.

15. Efficacy and Safety of Intravenous Labetalol in Acute Hypertensive Crisis in Children.

16. Isotopic response of labetalol-associated lichen planus pemphigoides on an old radiation site: A case report.

17. Hemodynamic Safety of Continuous Infusion Labetalol Versus Esmolol Combination Therapies for Type B Aortic Dissections.

18. Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?

19. Safety and efficacy of intravenous hydralazine and labetalol for the treatment of asymptomatic hypertension in hospitalised patients: A systematic review.

20. Distinct outcomes of labetalol exposed infants: case reports and systematic review.

21. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.

22. Juxtaglomerular Cell Tumor: A Rare, Curable Cause of Hypertension in a Young Patient.

23. Improving the use of intravenous antihypertensive medications in the hospital setting: a quality improvement initiative for patient safety.

24. Oral short-acting antihypertensive medications and the occurrence of stroke: a nationwide case-crossover study.

25. Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke.

26. Neonatal hypertension: cases, causes, and clinical approach.

27. Comparative evaluation of dexmedetomidine and labetalol for attenuating hemodynamic stress responses during laparoscopic cholecystectomy in borderline hypertensive patients.

28. Assess Before Rx: Reducing the Overtreatment of Asymptomatic Blood Pressure Elevation in the Inpatient Setting.

29. Safety of high-dose intravenous labetalol in hypertensive crisis.

30. Beta-blocker subtypes and risk of low birth weight in newborns.

31. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.

32. Associations of polymorphisms of CYP2D6 and CYP2C9 with early onset severe pre-eclampsia and response to labetalol therapy.

33. Use of Antihypertensive Medications and Uterotonics During Delivery Hospitalizations in Women With Asthma.

34. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.

35. The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.

36. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.

37. Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: A Randomized Controlled Trial.

38. In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.

39. Labetalol Use Is Associated With Increased In-Hospital Infection Compared With Nicardipine Use in Intracerebral Hemorrhage.

40. Neonatal haemodynamic effects following foetal exposure to labetalol in hypertensive disorders of pregnancy.

41. Response & Side Effects of Injectable Labetalol in Pregnancy Induced Severe Hypertension.

42. The efficacy of Labetalol versus Nitroglycerin for induction of controlled hypotension during sinus endoscopic surgery. A prospective, double-blind and randomized study.

43. Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.

44. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.

45. Hypertensive Emergencies in Pregnancy.

46. Medication error report: Intrathecal administration of labetalol during obstetric anesthesia.

47. [Toxic hepatocellular hepatitis due to labetalol].

48. First case report of acute generalized exanthematous pustulosis due to labetalol.

49. Asystole during electroconvulsive therapy.

50. A case of probable labetalol induced hyperkalaemia in pre-eclampsia.

Catalog

Books, media, physical & digital resources